Bariatric News is teaming up with Medtronic for World Obesity Day on 4th March 2021 and asking you to join the global community to raise awareness of obesity as a chronic disease, its causes and consequences, and call for action for impr

Eiger BioPharmaceuticals has announced positive results from the Phase 2 PREVENT study of Avexitide in patients with severe Post-Bariatric Hypoglycaemia (PBH), the outcomes were published in Journal of Clinical Endocrinology & Metabolism (Craig, C.M.